{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T03:13:08Z","timestamp":1785640388692,"version":"3.56.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":2684,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1093\/annonc\/mds360","type":"journal-article","created":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T08:24:49Z","timestamp":1347870289000},"page":"x294-x301","source":"Crossref","is-referenced-by-count":32,"special_numbering":"S10","title":["Pain management"],"prefix":"10.1016","volume":"23","author":[{"given":"C.I.","family":"Ripamonti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3 suppl","key":"10.1093\/annonc\/mds360_bb0010","first-page":"S1","article-title":"Subcommittee on taxonomy. Classification of chronic pain. Descriptors of chronic pain syndromes and definition of pain terms","author":"International association for the Study of Pain (IaSP)","year":"1986","journal-title":"Pain"},{"key":"10.1093\/annonc\/mds360_bb0015","series-title":"Cancer pain. assessment and management","first-page":"53","article-title":"Cancer pain syndromes","author":"Koh","year":"2010"},{"key":"10.1093\/annonc\/mds360_bb0020","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","article-title":"Prevalence of pain in patients with cancer: a systematic review of the past 40 years","volume":"18","author":"Van den Beuken-van Everdingen","year":"2007","journal-title":"ann Oncol"},{"key":"10.1093\/annonc\/mds360_bb0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11764-008-0047-0","article-title":"Barriers to pain assessment and management in cancer survivorship","volume":"2","author":"Sun","year":"2008","journal-title":"J Cancer Surviv"},{"key":"10.1093\/annonc\/mds360_bb0030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1526-4637.2006.00220.x","article-title":"Chronic pain in cancer survivor: a new frontier","volume":"8","author":"Burton","year":"2007","journal-title":"Pain Med"},{"key":"10.1093\/annonc\/mds360_bb0035","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/annonc\/mdn700","article-title":"Prevalence, distress, management and relief of pain during the last three months of cancer patients\u2019 life. Results of an Italian mortality follow-back survey","volume":"20","author":"Costantini","year":"2009","journal-title":"ann Oncol"},{"key":"10.1093\/annonc\/mds360_bb0040","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/annonc\/mdp001","article-title":"Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes","volume":"20","author":"Breivik","year":"2009","journal-title":"ann Oncol"},{"key":"10.1093\/annonc\/mds360_bb0045","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/sj.bjc.6605053","article-title":"Pattern and quality of care of cancer pain management. Results from the cancer pain outcome research study group","volume":"100","author":"apolone","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mds360_bb0050","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/j.leukres.2010.08.013","article-title":"Is pain in haematological malignancies under-recognised? The results from Italian ECaD-O survey","volume":"34","author":"Bandieri","year":"2010","journal-title":"Leukemia Res"},{"key":"10.1093\/annonc\/mds360_bb0055","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.leukres.2009.08.008","article-title":"Pain and emotional distress in leukemia patients at diagnosis","volume":"34","author":"Morselli","year":"2010","journal-title":"Leukemia Res"},{"key":"10.1093\/annonc\/mds360_bb0060","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0140-6736(03)13038-3","article-title":"15 million new cancer cases per year by 2020, says WHO","volume":"361","author":"Frankish","year":"2003","journal-title":"The Lancet"},{"key":"10.1093\/annonc\/mds360_bb0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0885-3924(01)00409-2","article-title":"The Steering Committee of the EaPC Research Network. Pain measurement tools and methods in clinical research in palliative care: recommendations of an expert working group of the European association of Palliative Care","volume":"23","author":"Caraceni","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/annonc\/mds360_bb0070","series-title":"Cancer Pain Relief","author":"World Health Organization","year":"1986"},{"key":"10.1093\/annonc\/mds360_bb0075","series-title":"Cancer Pain Relief","author":"World Health Organization","year":"1996"},{"issue":"Suppl 6","key":"10.1093\/annonc\/mds360_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/annonc\/mdr390","article-title":"Management of cancer pain: ESMO Clinical Practice Guidelines","volume":"22","author":"Ripamonti","year":"2011","journal-title":"ann Oncol"},{"key":"10.1093\/annonc\/mds360_bb0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3322\/caac.20112","article-title":"The management of cancer pain","volume":"61","author":"Paice","year":"2011","journal-title":"Ca Cancer J Clin"},{"issue":"2","key":"10.1093\/annonc\/mds360_bb0090","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1089\/jpm.2011.0296","article-title":"Strategic pain management: the identification and development of the International association for Hospice and Palliative Care (IaHPC) Opioid Essential prescription package","volume":"15","author":"Vignaroli","year":"2012","journal-title":"J Palliative Med"},{"key":"10.1093\/annonc\/mds360_bb0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.critrevonc.2008.12.005","article-title":"Cancer pain","volume":"70","author":"Ripamonti","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1093\/annonc\/mds360_bb0100","doi-asserted-by":"crossref","unstructured":"McNicol E, Strassels S, Gouds L. NSaIDs or paracetamol, alone or combined with opioids, for cancer pain (Cochrane Review). In the Cochrane Library Issue 1, 2006. Chichester: John Wyley.","DOI":"10.1002\/14651858.CD005180"},{"key":"10.1093\/annonc\/mds360_bb0105","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/0269216310378546","article-title":"Effectiveness of antiepilectic or antidepressant drugs when added to opioids for cancer pain: systematic review","volume":"25","author":"Bennett","year":"2011","journal-title":"Palliat Med"},{"key":"10.1093\/annonc\/mds360_bb0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/j.1875-9114.1990.tb02577.x","article-title":"a multiinstitutional evaluation of the analgesic efficacy and safety of ketorolac, tromethamine, acetaminophen plus codeine, and placebo in cancer pain","volume":"10","author":"Carlson","year":"1990","journal-title":"Pharmacotherapy"},{"key":"10.1093\/annonc\/mds360_bb0115","first-page":"411","article-title":"Drug therapy in severe tumor pain: comparative study of a new combination preparation versus diclofenac-Na","volume":"110","author":"Strobel","year":"1992","journal-title":"Fortsch Med"},{"key":"10.1093\/annonc\/mds360_bb0120","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1200\/JCO.1994.12.12.2756","article-title":"Efficacy and safety of nonsteroidal anti-inflammatory drugs for cancer pain: a meta-analysis","volume":"12","author":"Eisenberg","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds360_bb0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3959(96)03319-2","article-title":"Paracetamol with and without codeine in acute pain: a quantitative systematic review","volume":"70","author":"Moore","year":"1997","journal-title":"Pain"},{"key":"10.1093\/annonc\/mds360_bb0130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF02527888","article-title":"WHO step II: clinical reality or a didactic instrument?","volume":"8","author":"Freynhagen","year":"1994","journal-title":"Der Schmerz"},{"key":"10.1093\/annonc\/mds360_bb0135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jpainsymman.2006.01.001","article-title":"Low morphine doses in opioid-naive cancer patients with pain","volume":"31","author":"Mercadante","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/annonc\/mds360_bb0140","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00520-005-0807-6","article-title":"a validation study of the WHO analgesic ladder: a two-step vs three-step strategy","volume":"13","author":"Maltoni","year":"2005","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1093\/annonc\/mds360_bb0145","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0269216311405090","article-title":"The second step of the analgesic ladder and oral tramadol in the treatment of mild to moderate cancer pain. a systematic review","volume":"25","author":"Tassinari","year":"2011","journal-title":"Palliat Med"},{"key":"10.1093\/annonc\/mds360_bb0150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/0269216308088692","article-title":"The MERITOStudy: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during \u2018titration phase\u2019 in patients with cancer pain","volume":"22","author":"De Conno","year":"2008","journal-title":"Palliat Med"},{"key":"10.1093\/annonc\/mds360_bb0155","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/AJP.0b013e3181929b4f","article-title":"Normal release oral morphine starting dose in cancer patients with pain","volume":"25","author":"Ripamonti","year":"2009","journal-title":"Clin J Pain"},{"key":"10.1093\/annonc\/mds360_bb0160","first-page":"823","article-title":"Morphine in cancer pain: modes of administration. Expert Working Group of the European association for Palliative Care","volume":"312","author":"Hanks","year":"1996","journal-title":"BMJ"},{"key":"10.1093\/annonc\/mds360_bb0165","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidenced-based recommendations from the EaPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1093\/annonc\/mds360_bb0170","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002508-199909000-00003","article-title":"Intravenous titration with morphine for severe cancer pain: report of 28 cases","volume":"15","author":"Radbruch","year":"1999","journal-title":"Clin J Pain"},{"key":"10.1093\/annonc\/mds360_bb0175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cncr.10636","article-title":"Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion","volume":"95","author":"Mercadante","year":"2002","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds360_bb0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1191\/0269216303pm695oa","article-title":"Intravenous morphine for rapid control of severe cancer pain","volume":"17","author":"Harris","year":"2003","journal-title":"Palliat Med"},{"issue":"5","key":"10.1093\/annonc\/mds360_bb0185","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/0269216311401948","article-title":"a systematic review of oxycodone in the management of cancer pain","volume":"25","author":"King","year":"2011","journal-title":"Palliat Med"},{"issue":"5","key":"10.1093\/annonc\/mds360_bb0190","first-page":"471","article-title":"The role of hydromorphone in cancer pain treatment: a systematic review. Palliat Med","volume":"25","author":"Pigni","year":"2011"},{"key":"10.1093\/annonc\/mds360_bb0195","series-title":"Cancer pain. assessment and management,","first-page":"195","article-title":"Pharmacology of opioid analgesia: clinical principles","volume":"Vol. 11","author":"Ripamonti","year":"2010"},{"key":"10.1093\/annonc\/mds360_bb0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0885-3924(86)80042-2","article-title":"a randomized study on oral administration of morphine andmethadone in the treatment of cancer pain","volume":"1","author":"Ventafridda","year":"1986","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/annonc\/mds360_bb0205","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1200\/JCO.1998.16.10.3216","article-title":"Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?","volume":"16","author":"Ripamonti","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds360_bb0210","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0889-8588(02)00017-5","article-title":"The use of methadone for cancer pain","volume":"16","author":"Ripamonti","year":"2002","journal-title":"Hematol Oncol Clin North am"},{"key":"10.1093\/annonc\/mds360_bb0215","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1200\/JCO.1996.14.10.2836","article-title":"Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients","volume":"14","author":"De Conno","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds360_bb0220","unstructured":"US Food and DrugadministrationFDa issues second safety warning on fentanyl skin patch [news release]http:\/\/www.fda.gov\/bbs\/topics\/NEWS\/2007\/NEW01762.html"},{"key":"10.1093\/annonc\/mds360_bb0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/SPC.0b013e3283437a39","article-title":"Transdermal opioids for cancer pain","volume":"5","author":"Cachia","year":"2011","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1093\/annonc\/mds360_bb0230","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","article-title":"Expert Working Group of the EaPC Network. Strategies to manage the adverse effects of oral morphine: an evidence-based report","volume":"19","author":"Cherny","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds360_bb0235","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1200\/JCO.2001.19.11.2898","article-title":"Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study","volume":"19","author":"Mercadante","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds360_bb0240","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1002\/cncr.20712","article-title":"Opioid switching from transdermal fentanyl to oral methadone in patientswith cancer pain","volume":"101","author":"Benitez-Rosario","year":"2004","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds360_bb0245","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1200\/JCO.2005.13.128","article-title":"Rapid switching between transdermal fentanyl and methadone in cancer patients","volume":"23","author":"Mercadante","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds360_bb0250","first-page":"277","article-title":"Transdermal route as an alternative to oral administration of opioids in cancer pain","volume":"14","author":"Burza","year":"1998","journal-title":"Clin Ter"},{"key":"10.1093\/annonc\/mds360_bb0255","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/annonc\/mdq449","article-title":"First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the on study","volume":"22","author":"Garcia de Paredes","year":"2011","journal-title":"ann Oncol"},{"key":"10.1093\/annonc\/mds360_bb0260","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1007\/s10620-008-0651-x","article-title":"EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain. a meta-analysis and systematic review","volume":"54","author":"Puli","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1093\/annonc\/mds360_bb0265","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1200\/JCO.2010.32.2750","article-title":"Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable cancer","volume":"29","author":"Wyse","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds360_bb0270","first-page":"273","article-title":"Breakthrough pain: definition, prevalence and characteristics","volume":"3","author":"Portenoy","year":"1990","journal-title":"Pain"},{"issue":"3","key":"10.1093\/annonc\/mds360_bb0275","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.pain.2010.02.035","article-title":"assessment and classification of cancer breakthrough pain: a systematic literature review","volume":"149","author":"Haugen","year":"2010","journal-title":"Pain"},{"key":"10.1093\/annonc\/mds360_bb0280","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/AJP.0b013e3181edc250","article-title":"Epidemiology and pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients. Results from the cancer pain outcome research and study group","volume":"27","author":"Greco","year":"2011","journal-title":"Clin J Pain"},{"key":"10.1093\/annonc\/mds360_bb0285","first-page":"CDOO4311","article-title":"Opioids for the management of breakthrough episodic pain in cancer patients","volume":"1","author":"Zeppetella","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/annonc\/mds360_bb0290","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1185\/03007991003694340","article-title":"Efficacy of intranasal fentanyl spray vs other opioids for breakthrough pain in cancer","volume":"26","author":"Vissers","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1093\/annonc\/mds360_bb0295","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.pain.2010.07.028","article-title":"a multicenter, placebo-controlled, double-blind, multiple-crossover study of fentanyl pectin nasal spray (FPNS) in the treatment of breakthrough cancer pain","volume":"151","author":"Portenoy","year":"2010","journal-title":"Pain"},{"key":"10.1093\/annonc\/mds360_bb0300","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3959(00)00427-9","article-title":"Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate OTFC and morphine sulphate immediate release MSIR","volume":"1\u20132","author":"Coluzzi","year":"2001","journal-title":"Pain"},{"issue":"11","key":"10.1093\/annonc\/mds360_bb0305","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1185\/03007990903336135","article-title":"a comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain- an open label, randomized, cross-over trial","volume":"25","author":"Mercadante","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1093\/annonc\/mds360_bb0310","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jpainsymman.2010.11.004","article-title":"Consistency of efficacy, patient accettability and nasal tolerability of fentanyl pectin nasal spray compared with immediate-release morphine sulphate in breakthrough cancer pain","volume":"41","author":"Davies","year":"2011","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"10.1093\/annonc\/mds360_bb0315","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1185\/03007995.2011.583231","article-title":"Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain","volume":"27","author":"Uberall","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1093\/annonc\/mds360_bb0320","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/CCO.0b013e328352eabc","article-title":"Supportive Care in Cancer Unit (SCCU) at the NCI of Milan: a New Integrated Model of Medicine in Oncology","volume":"24","author":"Ripamonti","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1093\/annonc\/mds360_bb0325","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/annonc\/mdq155","article-title":"Impact of setting of care on pain management in patients with cancer: a multicentre cross-sectional study","volume":"21","author":"Sichetti","year":"2010","journal-title":"ann Oncol"},{"key":"10.1093\/annonc\/mds360_bb0330","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mds233","article-title":"Management of cancer pain: ESMO Clinical Practice Guidelines","author":"Ripamonti","year":"2012","journal-title":"ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419417961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419417961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/23\/suppl_10\/x294\/6686977\/mds360.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T12:59:36Z","timestamp":1714395576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419417961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":65,"alternative-id":["S0923753419417961"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mds360","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}